Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classesF-C Bidard, M-C Matthieu, P Chollet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I/II trial of continuous infusion vinorelbine for advanced breast cancerC Toussaint, J Izzo, M Spielmann, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patientsF Boue, Z Pastran, M Spielmann, et al.
The British Journal of Surgery|August 1, 1986
Conservative management of breast cancerD Sarrazin, J A Dewar, R Arriagada, et al.
Presse Medicale (Paris, France : 1983)|February 16, 1991
[Phase I trial of a recombinant human interleukin 2. Results in patients with disseminated solid tumors]T Tursz, T Dorval, P Berthaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancerJ M Nabholtz, K Gelmon, M Bontenbal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-upL Zelek, A Llombart-Cussac, P Terrier, et al.
Presse Medicale (Paris, France : 1983)|March 21, 1987
[Initial chemotherapy in the treatment of inflammatory breast cancers. 230 cases]J Rouëssé, M Spielmann, T Le Chevalier, et al.
Cancer Treatment Reports|June 1, 1985
Phase II study of elliptinium in advanced breast cancerJ G Rouësse, T Le Chevalier, P Caille, et al.
Pageof 15